The University of Southampton
University of Southampton Institutional Repository

Evaluation of high-throughput genomic assays for the Fc Gamma Receptor Locus

Evaluation of high-throughput genomic assays for the Fc Gamma Receptor Locus
Evaluation of high-throughput genomic assays for the Fc Gamma Receptor Locus

Cancer immunotherapy has been revolutionised by the use monoclonal antibodies (mAb) that function through their interaction with Fc gamma receptors (Fc?Rs). The low-affinity Fc?R genes are highly homologous, map to a complex locus at 1p23 and harbour single nucleotide polymorphisms (SNPs) and copy number variation (CNV) that can impact on receptor function and response to therapeutic mAbs. This complexity can hinder accurate characterisation of the locus. We therefore evaluated and optimised a suite of assays for the genomic analysis of the Fc?R locus amenable to peripheral blood mononuclear cells and formalin-fixed paraffin-embedded (FFPE) material that can be employed in a high-throughput manner. Assessment of TaqMan genotyping for FCGR2A-131H/R, FCGR3A-158F/V and FCGR2B-232I/T SNPs demonstrated the need for additional methods to discriminate genotypes for the FCGR3A-158F/V and FCGR2B-232I/T SNPs due to sequence homology and CNV in the region. A multiplex ligation-dependent probe amplification assay provided high quality SNP and CNV data in PBMC cases, but there was greater data variability in FFPE material in a manner that was predicted by the BIOMED-2 multiplex PCR protocol. In conclusion, we have evaluated a suite of assays for the genomic analysis of the Fc?R locus that are scalable for application in large clinical trials of mAb therapy. These assays will ultimately help establish the importance of Fc?R genetics in predicting response to antibody therapeutics.
1932-6203
1-13
Hargreaves, Chantal
19adb5c3-4559-4ebc-8c28-4c28767d225e
Iriyama, C.
ab06d9d6-5cf4-4428-b4b6-e56ed0e8b2f4
Rose-Zerilli, Matthew
08b3afa4-dbc2-4c0d-a852-2a9f33431199
Nagelkerke, S.Q.
fbc0ed44-f82d-4429-8462-22def16b7428
Hussain, Khiyam
9468f252-81d0-4251-b800-702433b610f8
Ganderton, R.
6c4ffe96-7eb0-4e77-9c17-306887497187
Lee, C.
774e8767-13f8-4725-bc9f-c1200ccd78ab
Kuijpers, T.W.
65c3b687-fc1f-4e61-bfcd-bdcf64c8396d
Potter, Nora
86a99047-494b-405b-a3f7-650c1dcd5838
Coupland, S.
ed503162-5583-4fe6-aca0-83feb63dae9b
Davies, Andrew
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Stackpole, M.
6f122876-06fe-493f-b86c-92a03cda1953
Oates, M.
891eca82-7d15-46c5-b372-aff463c57472
Pettitt, A.R.
2419c472-6d6f-4e71-ac40-d381e78cb7b0
Glennie, Martin
9f6f0eff-4560-48c2-80cd-0ec116110ded
Cragg, Mark
ec97f80e-f3c8-49b7-a960-20dff648b78c
Strefford, Jon
3782b392-f080-42bf-bdca-8aa5d6ca532f
Hargreaves, Chantal
19adb5c3-4559-4ebc-8c28-4c28767d225e
Iriyama, C.
ab06d9d6-5cf4-4428-b4b6-e56ed0e8b2f4
Rose-Zerilli, Matthew
08b3afa4-dbc2-4c0d-a852-2a9f33431199
Nagelkerke, S.Q.
fbc0ed44-f82d-4429-8462-22def16b7428
Hussain, Khiyam
9468f252-81d0-4251-b800-702433b610f8
Ganderton, R.
6c4ffe96-7eb0-4e77-9c17-306887497187
Lee, C.
774e8767-13f8-4725-bc9f-c1200ccd78ab
Kuijpers, T.W.
65c3b687-fc1f-4e61-bfcd-bdcf64c8396d
Potter, Nora
86a99047-494b-405b-a3f7-650c1dcd5838
Coupland, S.
ed503162-5583-4fe6-aca0-83feb63dae9b
Davies, Andrew
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Stackpole, M.
6f122876-06fe-493f-b86c-92a03cda1953
Oates, M.
891eca82-7d15-46c5-b372-aff463c57472
Pettitt, A.R.
2419c472-6d6f-4e71-ac40-d381e78cb7b0
Glennie, Martin
9f6f0eff-4560-48c2-80cd-0ec116110ded
Cragg, Mark
ec97f80e-f3c8-49b7-a960-20dff648b78c
Strefford, Jon
3782b392-f080-42bf-bdca-8aa5d6ca532f

Hargreaves, Chantal, Iriyama, C., Rose-Zerilli, Matthew, Nagelkerke, S.Q., Hussain, Khiyam, Ganderton, R., Lee, C., Kuijpers, T.W., Potter, Nora, Coupland, S., Davies, Andrew, Stackpole, M., Oates, M., Pettitt, A.R., Glennie, Martin, Cragg, Mark and Strefford, Jon (2015) Evaluation of high-throughput genomic assays for the Fc Gamma Receptor Locus. PLoS ONE, 10 (11), 1-13, [e0142379]. (doi:10.1371/journal.pone.0142379). (PMID:26545243)

Record type: Article

Abstract


Cancer immunotherapy has been revolutionised by the use monoclonal antibodies (mAb) that function through their interaction with Fc gamma receptors (Fc?Rs). The low-affinity Fc?R genes are highly homologous, map to a complex locus at 1p23 and harbour single nucleotide polymorphisms (SNPs) and copy number variation (CNV) that can impact on receptor function and response to therapeutic mAbs. This complexity can hinder accurate characterisation of the locus. We therefore evaluated and optimised a suite of assays for the genomic analysis of the Fc?R locus amenable to peripheral blood mononuclear cells and formalin-fixed paraffin-embedded (FFPE) material that can be employed in a high-throughput manner. Assessment of TaqMan genotyping for FCGR2A-131H/R, FCGR3A-158F/V and FCGR2B-232I/T SNPs demonstrated the need for additional methods to discriminate genotypes for the FCGR3A-158F/V and FCGR2B-232I/T SNPs due to sequence homology and CNV in the region. A multiplex ligation-dependent probe amplification assay provided high quality SNP and CNV data in PBMC cases, but there was greater data variability in FFPE material in a manner that was predicted by the BIOMED-2 multiplex PCR protocol. In conclusion, we have evaluated a suite of assays for the genomic analysis of the Fc?R locus that are scalable for application in large clinical trials of mAb therapy. These assays will ultimately help establish the importance of Fc?R genetics in predicting response to antibody therapeutics.

Text
2015 Hargreaves Strefford FCGR PLoS One - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 21 October 2015
Published date: 6 November 2015
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 384401
URI: http://eprints.soton.ac.uk/id/eprint/384401
ISSN: 1932-6203
PURE UUID: 2bfb5fb2-6775-4bf5-ab52-01baa530fe6a
ORCID for Matthew Rose-Zerilli: ORCID iD orcid.org/0000-0002-1064-5350
ORCID for Andrew Davies: ORCID iD orcid.org/0000-0002-7517-6938
ORCID for Mark Cragg: ORCID iD orcid.org/0000-0003-2077-089X
ORCID for Jon Strefford: ORCID iD orcid.org/0000-0002-0972-2881

Catalogue record

Date deposited: 04 Jan 2016 14:07
Last modified: 15 Mar 2024 03:36

Export record

Altmetrics

Contributors

Author: Chantal Hargreaves
Author: C. Iriyama
Author: S.Q. Nagelkerke
Author: Khiyam Hussain
Author: R. Ganderton
Author: C. Lee
Author: T.W. Kuijpers
Author: Nora Potter
Author: S. Coupland
Author: Andrew Davies ORCID iD
Author: M. Stackpole
Author: M. Oates
Author: A.R. Pettitt
Author: Martin Glennie
Author: Mark Cragg ORCID iD
Author: Jon Strefford ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×